Atria Investments Inc Has $3.83 Million Position in Kenvue Inc. $KVUE

Atria Investments Inc grew its position in Kenvue Inc. (NYSE:KVUE) by 24.3% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 183,176 shares of the company’s stock after purchasing an additional 35,806 shares during the period. Atria Investments Inc’s holdings in Kenvue were worth $3,834,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Evergreen Wealth Solutions LLC lifted its holdings in Kenvue by 2.6% during the 1st quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company’s stock valued at $402,000 after purchasing an additional 432 shares during the last quarter. Wealth Alliance LLC increased its holdings in shares of Kenvue by 1.6% during the first quarter. Wealth Alliance LLC now owns 31,778 shares of the company’s stock worth $762,000 after buying an additional 486 shares in the last quarter. Everett Harris & Co. CA increased its holdings in shares of Kenvue by 1.4% during the first quarter. Everett Harris & Co. CA now owns 36,971 shares of the company’s stock worth $887,000 after buying an additional 500 shares in the last quarter. Proffitt & Goodson Inc. raised its stake in shares of Kenvue by 8.2% in the second quarter. Proffitt & Goodson Inc. now owns 6,831 shares of the company’s stock valued at $143,000 after acquiring an additional 517 shares during the last quarter. Finally, UMB Bank n.a. boosted its holdings in shares of Kenvue by 22.3% in the 2nd quarter. UMB Bank n.a. now owns 2,853 shares of the company’s stock worth $60,000 after acquiring an additional 521 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on KVUE. Jefferies Financial Group dropped their price target on Kenvue from $25.00 to $23.00 and set a “buy” rating for the company in a report on Monday, October 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a research note on Tuesday, October 14th. Rothschild Redb upgraded shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 26th. Evercore ISI set a $18.00 price objective on shares of Kenvue in a report on Tuesday, October 28th. Finally, Rothschild & Co Redburn upgraded shares of Kenvue from a “neutral” rating to a “buy” rating and lowered their price objective for the company from $22.50 to $22.00 in a research report on Friday, September 26th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and an average price target of $20.17.

Kenvue Stock Up 1.1%

Shares of NYSE KVUE opened at $14.40 on Monday. The firm’s 50-day moving average is $17.21 and its 200-day moving average is $20.50. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $27.63 billion, a PE ratio of 19.45, a price-to-earnings-growth ratio of 2.07 and a beta of 0.72. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $25.17.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.29 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.01. The business had revenue of $3.84 billion during the quarter, compared to analysts’ expectations of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The firm’s quarterly revenue was down 4.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.32 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 26th. Investors of record on Wednesday, November 12th will be given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a dividend yield of 5.8%. The ex-dividend date is Wednesday, November 12th. Kenvue’s dividend payout ratio (DPR) is currently 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.